Batteries have the capability to tackle one of the most important social, economic, and scientific challenges of the 21st century, i.e., the ability to store electrical energy for decentralized stationary or mobile applications. At a global scale, across several sectors, exist multi-fold opportunities, and future battery technologies. Among different types of secondary batteries, lithium-ion is becoming a more popular battery technology, majorly due to its favorable capacity-to-weight ratio. Other factors in boosting its adoption include better performance, higher energy density, and declining price. The lithium-ion batteries were initially developed to serve the consumer electronics sector as these batteries last for a large number of charging cycles, have a high capacity-to-weight ratio, and high energy density, which makes them ideal for consumer electronics applications. The price of lithium-ion batteries is usually high compared to other batteries. However, leading players in the market have been investing to gain economies of scale and R&D activities to improve their performance and prices.

Currently, the largest application of silicone is in the construction industry, where its applications range from structural glazing and weatherproofing to energy- efficient materials used in the buildings. In the era of modern construction, silicone offers flexible solutions for the construction sector, which ranges from caulk, seals, coatings to intricate silicone profiles and expansive sections fitted to glass, steel, and plastics. Besides, silicone has facilitated the construction sector to produce wide range of custom solutions to offer insulation and protection benefits. Besides, silicone also helps to improve in-shop productivity and reduce material waste, while extending building life and reducing lifecycle costs. During 2018, the global construction industry grew by about 3.5%, and is further likely to witness growth in the coming years due to robust performance of the construction sector. Asia-Pacific and North American regions have been witnessing a strong growth in the residential construction sector. Asia-Pacific has been witnessing strong growth in the residential construction in countries, such as India, China, Philippines, Vietnam, and Indonesia. Besides in North America, high housing demand due to growing population and increased immigrants, and trend of nuclear families are some of the factors driving the residential construction in the region.

All fabrics are protective to some extent but protective clothing are not only concerned to protect just from daily needs but also from situations where hazards or risks are present and that have the potential to be life threatening or pose considerable potential for injury or damage to the person working in and around the hazard. The report exclusively focuses on current market trends and future growth opportunities in the protective clothing market. The report also focuses on various material, application and various end-user industries of protective clothing, which includes oil & gas, construction & manufacturing, pharmaceuticals, law enforcement & military, firefighting and others. Moreover, the report analyzes the current market trends of protective clothing in different geographies and suggests the future growth opportunities by analyzing government regulations & policies, thereby further increasing the consumer acceptance of protective clothing. The report covers profiles of the key industry participants in the protective clothing such as E. I. du Pont de Nemours and Company, Lakeland Industries, Inc., Ballyclare Limited, 3M Company, Koninklijke Ten Cate NV, Teijin Limited, Workrite Uniform Company, Inc., Cetriko S.L., W.L. Gore & Associates, Inc., and Glen Raven Inc.

The factors driving the overall market growth include increasing number of cancer patients, reduction in the cost of radiotherapy, and rising government and non-government investments in research and development of cancer treatment. Increasing number of cancer reported cases have been the primary factor for the demand for radiotherapy. According to World Health Organization (WHO) 2018 data on cancer, the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. Moreover, Cancer Research UK suggests that the population suffering from cancer is expected to increase in the future. The report suggests that there may be 27.5 million new cancer cases worldwide each year by 2040. As a result of rising cancer cases, government and non-government organizations have been investing in cancer research. Organizations, like Cancer Research UK (CRUK), has been actively involved in this pursuit for finding effective therapies, spending more than GBP 400 million a year on cancer research. Economies worldwide have also developed strategies to reduce the cost of radiotherapy, especially in middle-income and low-income economies. These strategies have helped the economies to save up to 50% cost for radiotherapy. These factors have positively affected and helped the growth of the market.

Neurological diseases are frequent in older adults, affecting around 55% of people aged 55 and older. They are associated with a high risk for adverse health outcomes, including mortality, disability, institutionalization, and hospitalization. Neurological diseases, like dementia and Parkinson’s disease, and strokes and headaches, are frequently encountered n eurological diseases in el derly patien ts. Neuromodula tion is an in tracranial, el ectrical neuromodulation therapy that has FDA approval for the treatment for several of the neurological diseases, such as bladder control, headache, tremors, chronic pain, stroke, minimally conscious state, and spinal cord injury, which are most found in the elderly population. There are multiple ways through which funding organizations, research teams, and non-profit organizations are collaborating with consumers to raise the awareness regarding this neurological diseases, globally. The educational campaigns also play a demanding role in making patients and families aware of the neurological diseases, particularly in the middle and low-income nations, where the focus of the government and healthcare facilities are geared more toward major disorders, such as Parkinson’s disease and Alzheimer's disease.

Neurology devices are used for the diagnosis and treatment of various neurological disorders. The report of the neurology devices market involves the study of different types of devices, including neurostimulation devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid management devices, and others. In addition, it covers the end users of the market, including hospitals, neurological clinics, and ambulatory care centers. Moreover, this report provides a detailed analysis of the current market trends and future estimations from 2019 to 2026.

The report provides market dynamics and trends related to the global nephrology devices market. In addition, it presents the market estimations and forecast of the market. It includes revenue generated from the sales of devices such as dialysis instrument, lithotripter, dialysis catheters, and other products, which are provided by key players. For the purpose of analysis, the global nephrology devices market is segmented into device type and region. The study estimates revenue generated from the sales of nephrology devices. On the basis of device type, the market is divided into dialysis instrument, lithotripter, dialysis catheters, and others. This further provides an understanding of the use of nephrology devices. Moreover, the report covers revenue generated from the sales of nephrology devices offered across regions such as North America, Europe, Asia-Pacific, and LAMEA.

HnB device is a battery-powered inhaler that simulates tobacco smoking. A heated tobacco vapor product device is also known as a tobacco heating product or, most commonly, an HnB device. It contains tobacco in either leaf or granular form. The device heats the tobacco, directly or indirectly, instead of burning it to form tobacco- enriched inhalable vapors.

The increasing rates of product innovations in the Indonesian and Malaysian markets are extensively driving the sales of whipping cream. The manufacturing companies are concentrating on the individual demands of the consumers, such as halal-certified, lactose-intolerance, clean-label, and soy-free products. Owing to a large presence of the Muslim population in these countries, the demand for halal-certified food products has witnessed a surge. Thus, the manufacturing brands, such as Anchor and Embog, are producing halal-certified whipping cream with proper labelling, to entice the consumers.  For instance, Indonesia only accepts its own Halal body. Thus Fonterra, a New Zealand-based company, launched a generic halal logo, which is used in anchor whipping cream, to share the same packaging with Indonesia. In Malaysia, the concentration of lactose-intolerant consumers is high, leading to the demand for lactose-free whipping cream. Thus, the manufacturers are introducing lactose-free whipping cream, to satiate the consumers’ demands. For instance, the brand, Paul's, offers lactose-free and gluten-free thickened cream made of cream, skimmed milk, milk solids, gelatin, and other ingredients. The product is apt for whipping, pouring, and cooking, resulting in its diverse application in the foodservice sector.

The growth of the market studied is currently being driven by various factors, including the increasing pet ownership and animal health expenditure, increased burden of animal zoonotic diseases, and the growing pet insurance and animal health investments made by the pharmaceutical companies.  The recent years have observed an increasing adoption of pet animals every year. Not only the pet ownership, but also the number of farm population has increased at a steady rate. There is also a high adoption of pigs across billions of farms all over the world.  Moreover, there is an increase in the immune mediated diseases in animals, which has driven the market for new immunodiagnostic tests. ELISA is a highly sensitive means of detecting relatively low levels of molecules within a biological fluid. For this reason, it is a very commonly used immunodiagnostic test and is applied to a wide variety of samples from different body fluids.